What the Pandemic Is Telling Us About Science, Politics, and Values
By Daniel Sarewitz,
Slate
| 03. 24. 2020
For the past 30 years, I have tried to make sense of the interactions between science and politics, especially the challenge of making decisions under conditions of uncertainty and disagreement. Why—despite huge and ever-expanding bodies of relevant scientific research—is it so impossible to resolve disagreements around climate change, nuclear energy, mammograms, K–12 public education, chemicals in the environment, genetically modified organisms, nutritional guidelines, trade policy, and on and on? Why, despite all the research and expertise, do the opposing sides of these debates remain fixed in their values and interests, certain in their own version of the facts and immovable in their sense of what should or should not be done?
Thanks to the COVID-19 pandemic, the relation between science and politics is now at the center of the world stage. The novel coronavirus offers up a powerful and extremely clear lesson about the appropriate role of science in helping to guide us toward a better future—a lesson that sharply contradicts standard thinking about science and politics. Above all, we are learning that science’s place in politics is determined not...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...